RecruitingPhase 3NCT06713837

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Studying Inherited acute myeloid leukemia

Last synced from ClinicalTrials.gov May 11, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Principal Investigator: Giovanni Martinelli, MD, Prof, MD
University of Bologna
Intervention: High intensity therapies(drug)
Enrollment: 339 target
Eligibility: 18 years · All sexes
Timeline: 2025 – 2028

Study locations (30)

University Hospital Brno, Brno, Czechia
University Hospital Hradec Králové, Hradec Králové, Czechia
University Hospital Olomouc, Olomouc, Czechia
University Hospital in Ostrava, Ostrava, Czechia
University Hospital in Pilsen, Pilsen, Czechia
Uniklinik RWTH Aachen, Aachen, Germany
University Hospital Greifswald, Greifswald, Germany
Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH, Halle, Germany
University Hospital Halle, Halle, Germany
University Hospital of Rostock, Rostock, Germany
Heinrich-Braun-Klinikum gGmbH, Zwickau, Germany
Policlinico Sant'Orsola, Bologna, BO, Italy
IRCCS Ospedale Policlinico San Martino, Genova, GE, Italy
Ospedali Riuniti Villa Sofia - Cervello, Palermo, PA, Italy
Ospedale S.Spirito - ASL Pescara, Pescara, PE, Italy
+15 more locations on ClinicalTrials.gov

Collaborators

Hospital Vall d'Hebron · Cyprus Institute of Neurology and Genetics · European Leukemia Net · Fundacion Para La Investigacion Hospital La Fe · Ostdeutsche Studiengruppe Haematologie Und Onkologie e.V. · Ospedale Pediatrico Bambin Gesù · Czech Lymphoma Study Group · Charite University, Berlin, Germany · Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León · University of Bologna · Hannover Medical School · German Society for Pediatric Oncology and Hematology GPOH gGmbH · Toscana Life Sciences Sviluppo s.r.l. · Lithuanian University of Health Sciences · Gruppo Italiano Malattie EMatologiche dell'Adulto · TIMELEX

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06713837 on ClinicalTrials.gov

Other trials for Inherited acute myeloid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Inherited acute myeloid leukemia →

← Back to all trials